Biomerica Inc
General ticker "BMRA" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $5.4M
Biomerica Inc does not follow the US Stock Market performance with the rate: -36.9%.
Estimated limits based on current volatility of 4.8%: low 0.27$, high 0.30$
Factors to consider:
- North America accounted for 27.5% of revenue in the fiscal year ended 2023-05-31
- Current price 36.7% below estimated low
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-05-31 to 2026-05-31
- 2024-05-31 to 2025-05-31 estimated range: [0.43$, 1.31$]
- 2025-05-31 to 2026-05-31 estimated range: [0.59$, 1.64$]
Financial Metrics affecting the BMRA estimates:
- Negative: Non-GAAP EPS, $ of -0.36 <= 0.10
- Negative: Operating profit margin, % of -54.04 <= 1.03
- Negative: Operating cash flow per share per price, % of -34.26 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -1.64 <= 3.85
Short-term BMRA quotes
Long-term BMRA plot with estimates
Financial data
| YTD | 2022-05-31 | 2023-05-31 | 2024-05-31 |
|---|---|---|---|
| Operating Revenue | $18.87MM | $5.34MM | $5.42MM |
| Operating Expenses | $23.41MM | $12.56MM | $11.78MM |
| Operating Income | $-4.53MM | $-7.22MM | $-6.37MM |
| Non-Operating Income | $0.03MM | $0.13MM | $0.43MM |
| R&D Expense | $1.81MM | $1.58MM | $1.49MM |
| Income(Loss) | $-4.51MM | $-7.09MM | $-5.94MM |
| Taxes | $0.02MM | $0.05MM | $0.04MM |
| Profit(Loss) | $-4.53MM | $-7.14MM | $-5.98MM |
| Stockholders Equity | $8.32MM | $11.72MM | $6.59MM |
| Inventory | $2.42MM | $2.06MM | $2.38MM |
| Assets | $11.37MM | $14.45MM | $9.25MM |
| Operating Cash Flow | $-0.48MM | $-5.47MM | $-5.36MM |
| Capital expenditure | $0.17MM | $0.08MM | $0.12MM |
| Investing Cash Flow | $-0.17MM | $-0.08MM | $-0.12MM |
| Financing Cash Flow | $2.39MM | $9.39MM | $-0.08MM |
| Earnings Per Share* | $-0.36 | $-0.50 | $-0.36 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.